Reconsideration of Lung Cancer, July 10, 1998

Reconsideration of Lung Cancer, July 10, 1998

Lung cancer is the most common cancer among men, ranking first among all cancers, with a male-to-female ratio of 6:1, indicating that women are less likely to develop lung cancer. Smoking, asbestos, and heavy metal salts are risk factors for lung cancer; here, the significance of asbestos-related pneumoconiosis should be recognized, as multiple myeloma (MM) is closely linked to asbestos. Pathologically, about half of lung cancers are squamous cell carcinomas, while adenocarcinomas and undifferentiated carcinomas account for the other half. Some sources report that adenocarcinomas are more prevalent, while others claim that undifferentiated carcinomas are more common. The term “undifferentiated” refers to undifferentiated carcinomas. Squamous cell carcinomas tend to be centrally located, whereas adenocarcinomas are more peripheral. Squamous cell carcinomas are more common in men aged 50–60, while undifferentiated carcinomas are more prevalent among young men. Adenocarcinomas, on the other hand, are more common in women. Diagnosis of lung cancer depends on: ① Medical history: Untreated lung cancer has a survival rate of less than 10% within one year. Statistics show that surgical treatment yields a 73.3% one-year survival rate, while chemotherapy alone achieves 36%. Without any treatment, the one-year survival rate is less than 10%. Combining surgery and chemotherapy can raise the survival rate to 97% (according to “Practical Clinical Oncology,” page 120), applicable to non-small cell lung cancer. Small cell lung cancer, however, has an average lifespan of less than six months, but it is highly sensitive to chemotherapy, with a one-year survival rate of 50% after treatment. Without treatment, the average survival time is less than six months. ② Chest X-ray: Lobulation, spiculation (radiating crown), high density, and peripheral blurring are the four key features. Due to varying clinical experience and practices, physicians’ interpretations differ, so clinical decisions should be flexible and not rely solely on radiological diagnosis. ③ CT scans are superior to X-rays for diagnosing lung cancer, providing cross-sectional images, making them particularly useful when the nature of the mass is uncertain. At the same time, tumor markers should also be used in diagnosing lung cancer; ferritin, carcinoembryonic antigen, and β antibodies all have certain diagnostic value.